Segment Reporting - Schedule of Research and Development Expenses (Details) - Research and Development Activities Segment - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting [Line Items] | ||||
| External clinical development expenses | $ 1,712,599 | $ 11,723,402 | $ 7,041,837 | $ 16,625,769 |
| Personnel related and stock-based compensation | 1,644,315 | 1,408,024 | 3,357,113 | 2,745,773 |
| Other research and development expenses | 585,018 | 1,206,327 | 1,478,662 | 2,163,468 |
| Total research and development expenses | 3,941,932 | 14,337,753 | 11,877,612 | 21,535,010 |
| SBI-100 | ||||
| Segment Reporting [Line Items] | ||||
| External clinical development expenses | 0 | 0 | 0 | 2,241 |
| nimacimab | ||||
| Segment Reporting [Line Items] | ||||
| External clinical development expenses | $ 1,712,599 | $ 11,723,402 | $ 7,041,837 | $ 16,623,528 |
| X | ||||||||||
- Definition External Clinical Development Expenses No definition available.
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|